Biotechnology Events


Updates and Additions for the Database 10/18/16

Submitted by Biotech Team on Tue, 10/18/2016 - 08:23.

Today's updates and additions to the Biotechnology Events database can be found at the top. We will be making updates available throughout the day. Past entries are listed below.


Updates for October 18, 2016

1) The Medicines Company, Inc. - The Medicines Company Announces Positive Top-Line Results from Day 90 Interim Analysis in Ongoing ORION-1 Phase 2 Study of PCSK9si


Updates for October 05, 2016

Regulatory Event - Watch List 09/19/16

Submitted by Biotech Team on Mon, 09/19/2016 - 08:22.

Updated Regulatory Watch List as of: 09/19/16

The following is a list of companies with near term regulatory events pending:

US Approval

FDA PDUFA Date (FDA Decision date)


Emergent BioSolutions, Inc. - August 15, 2016
BioThrax Building 55 licensure - . (APPROVED)

Portola Pharmaceuticals, Inc. - August 17, 2016
Andexanet alfa -

Sanofi - August 22,2016
Insulin Glargine and Lixisenatide -

Amgen Inc. - August 24, 2016

Clinical Data Event - Watch List 9/02/15

Submitted by Biotech Team on Wed, 09/02/2015 - 08:20.

Updated Clinical Data Watch List as of: 9/02/15.


The following is a list of companies with near term (within one year) phase III clinical data read-outs pending:


Updates coming soon.


Strategy Definitions

Submitted by Biotech Team on Thu, 01/26/2012 - 19:23.

Disclaimer: Trading Securities is Risky. A trader is subject to this risk and can lose money. Please read the "Terms of Use Section" of the website prior to any and all uses of the content contained on the pages of the website.


How to use the Database SEARCH FEATURE

Submitted by Biotech Team on Mon, 01/24/2011 - 21:11.

BiotechnologyEvents.Com offers a unique and powerful tool that allows the user to mine the biotechnology sector for the all important events that effect the future success of the biotech companies covered.

Syndicate content